What are the Two of the Best Hedge Fund Managers of 2013 Buying?

Over the past few weeks, most hedge funds in the U.S. have been filing their Form 13Fs with the Securities and Exchange Commission, disclosing their long equity positions as of March 31. In this article, I will take a look at David Tepper’s Appaloosa Management Lp and Larry Robbins’ Glenview Capital’s most relevant bullish moves that took place in Q1. But, why these funds?

According to an Insider Monkey article published a couple of months ago, Mr. Tepper and Mr. Robbins are among the three best hedge fund managers of 2013, along with Michael Castor of Sio Capital. As this last fund doesn’t file 13Fs, because it had an equity portfolio smaller than $100 million by the end of 2013, which makes it exempted from disclosing its equity portfolio, we will only look into Appaloosa’s and Glenview’s holdings from the latest 13F. However, we should highlight that Sio Capital returned an impressive 23% during the first four months of the year, widely outperforming the S&P 500, which was barely up during the same period.

David Tepper

First off is Citigroup Inc (NYSE:C), a famed $142 billion market cap financial services holding company. During the first quarter, both Appaloosa Management and Glenview Capital increased their stakes in this firm. The latter upped its bets by 64%, to 5.18 million shares, worth more than $240 million, while the former inched up its position by 4%, to 10.08 million shares, valued at more than $470 million. Another hedge fund placing big bets on Citigroup is Boykin Curry’s Eagle Capital Management, which started a position in the company, with 15.23 million shares held as of the end of the first quarter. Ken Griffin‘s Citadel Investment Group is another shareholder with a significant position which amasses around 9.92 million shares.

Second in this list is HCA Holdings Inc (NYSE:HCA), a $22.9 billion market cap health care services company. This is Glenview Capital’s third most valuable holding, worth more than $660 million. Its position remained unchanged over the first quarter (12.84 million shares), and so is the largest hedge fund shareholder of the company.

Appaloosa Management’s owns 5.3 million shares of the healthcare company, adding around 225,500 shares during the first three months. Other major funds that own shares of the company are Lee Ainslie’s Maverick Capital, William B. Gray’s Orbis Investment Management, and Keith Meister’s Corvex Capital, which own more than 4 million shares each.

Finally, there’s two more cases that we would like to look into. The first one is that of American International Group Inc (NYSE:AIG), an insurance behemoth with more than $76 billion in market cap. While Glenview increased its participation by 14%, to 9.85 million shares (worth about $520 million), Appaloosa halved its exposure to the stock, and now holds 1.22 million shares (valued at about $61.26 million).

Another case, which is very similar to the previous one, is that of General Motors Company (NYSE:GM), a $55 billion market cap automaker that saw Appaloosa increase its stakes by 2.92 million shares, to 7.88 million shares (worth about $270 million). On the opposite, Mr. Robbins’ fund shrank its investment in the company by 22% and now owns 4.94 million shares, worth $170 million. Warren Buffett‘s Berkshire Hathaway also cut its stake by 10.00 million shares, owning 30.00 million shares, valued at $1.03 billion as of the end of March.

Although the aforementioned cases are not clear examples of bullishness, the bets that both funds hold on these stocks are not to be overlooked. All of the companies in this list offer very decent (usually above-average) growth projections for the next five years to come, and certainly deserve a closer look in order to elucidate if they stand as attractive investment options.

Disclosure: Javier Hasse holds no position in any stocks mentioned.

Recommended Reading:

Billionaire Larry Robbins’ Top Stock Picks

Billionaire David Tepper is Betting on These Stocks

Free Stock Research Report: URS Corp (URS)

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!